Correlation Between Vaccinex and Illumina
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Illumina at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Illumina into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Illumina, you can compare the effects of market volatilities on Vaccinex and Illumina and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Illumina. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Illumina.
Diversification Opportunities for Vaccinex and Illumina
Excellent diversification
The 3 months correlation between Vaccinex and Illumina is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Illumina in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Illumina and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Illumina. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Illumina has no effect on the direction of Vaccinex i.e., Vaccinex and Illumina go up and down completely randomly.
Pair Corralation between Vaccinex and Illumina
Given the investment horizon of 90 days Vaccinex is expected to under-perform the Illumina. In addition to that, Vaccinex is 3.83 times more volatile than Illumina. It trades about -0.02 of its total potential returns per unit of risk. Illumina is currently generating about 0.08 per unit of volatility. If you would invest 13,026 in Illumina on September 1, 2024 and sell it today you would earn a total of 1,389 from holding Illumina or generate 10.66% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Vaccinex vs. Illumina
Performance |
Timeline |
Vaccinex |
Illumina |
Vaccinex and Illumina Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vaccinex and Illumina
The main advantage of trading using opposite Vaccinex and Illumina positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Illumina can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will offset losses from the drop in Illumina's long position.Vaccinex vs. Tff Pharmaceuticals | Vaccinex vs. Eliem Therapeutics | Vaccinex vs. Inhibrx | Vaccinex vs. Enliven Therapeutics |
Illumina vs. Thermo Fisher Scientific | Illumina vs. Danaher | Illumina vs. Waters | Illumina vs. IDEXX Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |